Drug discovery

#Antigen #Cancer vaccine #Drug development #Drug discovery #Infinitopes #Society of Immunotherapy for Cancer (SITC)

Breakthroughs on cancer vaccine development at SITC 2024 

Infinitopes presented three posters on its cancer vaccine discovery and development strategy, including one that has been recognised as a ‘top 100’ poster presentation, at the Society for Immunotherapy of Cancer (SITC) 2024, held in Houston, US, from 6-10 November.  A spinout from Oxford University, supported by Cancer Research UK (CRUK),… Read More

#Cancer Research #News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Register now: Discover areas of opportunity in CGT drug discovery

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#Artificial intelligence (AI) #Drug discovery #In Focus Report #Machine learning #Market reporting

Download the report: How AI and ML are improving drug discovery

Artificial intelligence (AI) and machine learning (ML) are helping drive efficiencies across drug discovery and development processes and represent exciting tools that teams can utilise to bring therapies to patients. Created by DDW and sponsored by Benchling, ‘AI & ML: How technology is improving drug discovery’ is a free… Read More

#News

#Artificial intelligence (AI) #Drug discovery #In Focus Report #Machine learning #Market reporting

AI and ML: How technology is improving drug discovery

Created by DDW and sponsored by Benchling, ‘AI & ML: How technology is improving drug discovery’ is a free In Focus report available to download now. Artificial intelligence (AI) and machine learning (ML) are helping drive efficiencies across drug discovery and development processes and represent exciting tools that teams can… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Drug discovery #Investment #Life sciences

Podcast: Investment trends for drug discovery and development

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Owen Smith, Partner at… Read More

#News

#4BIO Capital #Drug development #Drug discovery #Investment #Life sciences

New podcast: Investment trends for drug discovery and development

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Owen Smith, Partner at… Read More

#News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

What will the future bring in cell and gene therapies?

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#AI / data analytics / healthtech / informatics #Business #Digital solutions #Digital workflow #Drug development #Drug discovery #EMA #FDA #Marketing #Pharmaceuticals #Regulatory

New podcast: How to streamline regulatory approval

This is the latest episode of the free DDW narrated podcast, titled “How to streamline regulatory approval”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Quicker time to regulatory submission through improved data management and The… Read More

#News #Regulatory

Flow cytometry
#Drug discovery #Flow Cytometry #Lab technology #Tech Focus

Flow cytometry: Shining a light on new therapeutics

Diana Spencer explores the latest innovations in flow cytometry technology and the potential for the technique in the future of drug discovery. Flow cytometry is a technique used to rapidly analyse single cells to characterise their physical, chemical and biological properties. The technology was invented in 1968 by Wolfgang Göhde… Read More

#Exclusive Content

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Register now for DDW’s Cell & Gene Therapy Showcase

Join the DDW Cell & Gene Therapy Showcase, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery & development sector as well as highlighting challenges… Read More

#News

Cancer research in laboratory
#Breast cancer #Drug approvals #Drug discovery #Oncology

Early breast cancer drug Kisqali gets EU recommendation 

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting marketing authorisation for Novartis’ Kisqali (ribociclib).  The positive opinion relates to the adjuvant treatment of adults with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) early breast cancer (EBC),… Read More

#Cancer Research #News

Diversity
#Clinical trials #Diversity #Drug development #Drug discovery #FDA #Inclusivity

Opinion: Are FDA plans enough to boost inclusivity within clinical trials?

DDW Editor Reece Armstrong examines whether recent FDA plans to boost diversity within clinical trials are enough to tackle the scale of the problem. In June this year, the US Food and Drug Administration (FDA) issued draft guidance designed to help boost the engagement of underrepresented communities within clinical… Read More

#Exclusive Content

#Biopharma #Drug development #Drug discovery #Oncology #Partnership

Sanofi and Orano invest in potential of radioligand cancer medicines 

Sanofi and Orano Med have entered into an agreement with the aim of accelerating the development of radioligand medicines.  Building on the radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand.  The new entity… Read More

#News

Woman with painful shoulder
#Clinical trials #Drug development #Drug discovery #Phase I trial

Novel pain relief drug enters Phase I trials 

The first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist, which it is hoped will treat chronic pain without the potential for abuse.   The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and… Read More

#News

Neuroscience innovation
#Drug development #Drug discovery #Neuroscience #Webinar

Watch DDW’s Neuroscience Showcase On Demand

In this free online event at 3pm BST on 24 October, hosted by DDW and co-sponsored by ApconiX and AxoSim, leading industry figures outline the areas of opportunity and challenges in the neuroscience drug discovery & development sector.  The showcase includes a panel discussion looking at… Read More

#News